{"id":6708,"date":"2021-06-10T16:51:21","date_gmt":"2021-06-10T14:51:21","guid":{"rendered":"http:\/\/neu.advitos.com\/?p=6708"},"modified":"2023-08-10T12:08:05","modified_gmt":"2023-08-10T10:08:05","slug":"advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f","status":"publish","type":"post","link":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/","title":{"rendered":"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t10.06.2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Munich \/ Paris \/ Frankfurt am Main<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

ADVITOS GmbH (\u201cADVITOS\u201d), a Munich-based medical technology company, today announced the completion of a EUR 20 million financing round. The financing round was led by Cr\u00e9dit Mutuel Equity via its two subsidiaries Cr\u00e9dit Mutuel Equity Germany and Cr\u00e9dit Mutuel Innovation. In addition, ADVITOS received funding from the European Union\u2019s European Innovation Council (EIC) Fund as part of the EIC Accelerator Pilot blended finance program.<\/strong><\/p>

ADVITOS developed and markets the ADVOS multi-device (ADVanced Organ Support) to provide an integrated 4-in-1 multi-organ support therapy that enables simultaneous support of all three main detoxification organs \u2013 liver, lungs and kidney \u2013 and corrects blood acid-base imbalances. Pilot trials in critically ill patients have shown that this therapy increased survival in severe organ failure from 20% up to 50%.<\/p>

Multi-organ failure causes the deaths of approximately half a million intensive care patients in Western Europe and the USA every year. This is about 60 percent of all deaths in intensive care units. Due to the Covid-19 pandemic, this number has increased to around 750,000 patients in the past year. On the other hand, conventional extracorporeal procedures such as mechanical ventilation, ECMO (extracorporeal membrane oxygenation), dialysis and liver-assist therapy only support the function of one or two organs. By treating all three organs simultaneously, and not consecutively like with existing solutions, it is a holistic approach giving the patients a much better chance to recover. The ADVOS therapy is CE marked, recognized by international experts, and is already in use in the intensive care units of over 20 hospitals throughout Germany, including a number of leading university hospitals.<\/p>

ADVITOS developed key proprietary components of the ADVOS therapy and the ADVOS multi-device on its own and holds several patents related to technology and process features. With the current financing round, the company intends to further increase medical evidence through clinical trials, expand its commercialization internationally and to add additional therapy features to increase ease of use of the ADVOS multi.<\/p>

ADVITOS was founded in 2005 by nephrologist Bernhard Kreymann, M.D., who is also the inventor of the ADVOS therapy. ADVITOS began as a start-up in a research laboratory in Garching near Munich. Catherine Schreiber complemented Bernhard Kreymann with her business and engineering background. Together they developed ADVITOS over the years with the help of several financing rounds with the participation of private investors, the KfW banking group and employees. The company presently employs 55 people. It has received numerous awards, including the 2020 Innovation Award Bavaria, and is listed in the Deloitte Technology Fast 50 Awards 2019.<\/p>

Bernhard Kreymann, founder and CEO of ADVITOS, said: \u201cThis financing round is a major step in the further development of ADVITOS. It will enable us to grow much faster in the future and to embark on several major development projects in both research & development and sales & marketing. Together with our new financing partners, we are also gaining an incredibly diverse set of competencies and expertise to support these projects and open new doors for ADVITOS.\u201d<\/p>

Delphine Cardi, PhD, Investment Director at Cr\u00e9dit Mutuel Innovation in Paris, added: \u201cWith this round of financing, we are extremely pleased to support not only an economically promising company but above all to improve the medical care of critically ill patients.\u201d<\/p>

S\u00e9bastien Neiss, Managing Director of Cr\u00e9dit Mutuel Equity in Germany, further comments: \u201cIt was important to us to make a sustainable contribution to the future of the company and its mission. To this end, ADVITOS not only receives venture capital from our colleagues at Cr\u00e9dit Mutuel Innovation in France, the EIC Fund and other co-investors. Through the participation of Cr\u00e9dit Mutuel Equity, we will also support the international development of ADVITOS by making available long-term growth capital that is not dependent on predefined time horizons. This will enable us to adapt to the growth dynamics of the company and, if required, enables us to reinvest in case of changes in the shareholder structure or future growth projects.\u201d<\/p>

Laura Gonz\u00e1lez-Est\u00e9fani, EIC Fund Investment Committee member, said: \u201cWe are delighted to announce that the EIC Fund is supporting ADVITOS in this successful financial round. This allows this highly innovative company to further develop their product and bring it closer to the market\u201d.<\/p>

Mathias Klingler, chairman of the supervisory board of ADVITOS and authorized representative of the main private investor, sees the financing round as a great opportunity to use the unique therapy from ADVITOS internationally for the further benefit of patients and thus save lives.<\/p>

About Cr\u00e9dit Mutuel Equity<\/strong><\/p>

Cr\u00e9dit Mutuel Equity (formerly CIC Capital) is the private equity subsidiary of Cr\u00e9dit Mutuel Alliance F\u00e9d\u00e9rale and carries out venture capital, growth capital and buyout activities.<\/p>

Cr\u00e9dit Mutuel Equity supports business leaders at all stages of their companies\u2019 development, from seed phase to buyout, by providing them with the means and the time required to implement their transformational projects. Cr\u00e9dit Mutuel Equity brings together a network of over 350 business leaders and entrepreneurs who share similar convictions and can benefit from one another\u2019s experience, no matter the nature of their projects. Using its own funds (\u20ac3.0 billion), Cr\u00e9dit Mutuel Equity makes investments tailored to the time horizons and growth strategies of the companies in which it invests, whether in France, Canada, the United States, Germany or Switzerland.<\/p>

For more information, see www.creditmutuel-equity.eu<\/a><\/p>

About Cr\u00e9dit Mutuel Innovation<\/strong><\/p>

Cr\u00e9dit Mutuel Innovation is the venture capital subsidiary of Cr\u00e9dit Mutuel Equity. Its objective is to invest in companies developing promising technologies. Cr\u00e9dit Mutuel Innovation selects companies with strong growth potential in dynamic sectors such as information technology, telecommunications, electronics, life sciences, new materials and environment. For more than 15 years, Cr\u00e9dit Mutuel Innovation has invested \u2013 and often reinvested \u2013 its own capital to support innovative companies all along their development. Cr\u00e9dit Mutuel Innovation\u2019s policy is to provide long-term equity support to innovative startups to streamline their chances of success.<\/p>

For more information, see www.creditmutuel-equity.eu<\/a><\/p>

About Cr\u00e9dit Mutuel Alliance F\u00e9d\u00e9rale<\/strong><\/p>

One of France\u2019s leading bank insurers, operating through nearly 4,300 branches serving 26.7 million customers, Cr\u00e9dit Mutuel Alliance F\u00e9d\u00e9rale offers a diversified range of services to a wide range of customers, from private individuals and local professionals to businesses of all sizes.<\/p>

One of Europe\u2019s strongest banking groups, its shareholders\u2019 equity amounted to \u20ac49.6 billion and its CET1 ratio was 17.8% at 30 December 2020.<\/p>

Cr\u00e9dit Mutuel Alliance F\u00e9d\u00e9rale is made up of the following Cr\u00e9dit Mutuel federations: Centre Est Europe (Strasbourg), Sud-Est (Lyon), Ile-de-France (Paris), Savoie-Mont Blanc (Annecy), Midi-Atlantique (Toulouse), Loire-Atlantique et Centre-Ouest (Nantes), Centre (Orl\u00e9ans), Normandie (Caen), Dauphin\u00e9-Vivarais (Valence), M\u00e9diterran\u00e9en (Marseille), Anjou (Angers), Massif Central (Clermont-Ferrand) and Antilles-Guyane (Fort-de-France).<\/p>

Cr\u00e9dit Mutuel Alliance F\u00e9d\u00e9rale also encompasses Caisse F\u00e9d\u00e9rale de Cr\u00e9dit Mutuel, Banque F\u00e9d\u00e9rative du Cr\u00e9dit Mutuel (BFCM) and all its subsidiaries, including CIC, Euro-Information, Assurances du Cr\u00e9dit Mutuel (ACM), Targobank, Cofidis Group, Banque Europ\u00e9enne du Cr\u00e9dit Mutuel (BECM), Banque de Luxembourg, Banque Transatlantique and Homiris.<\/p>

For more information, see www.creditmutuelalliancefederale.fr<\/a><\/p>

About the European Innovation Council Fund<\/strong><\/p>

Established in June 2020, the European Innovation Council Fund (EIC Fund) is a breakthrough initiative of the European Commission to make direct equity and quasi-equity investments (between \u20ac500.000 and \u20ac15 million) in European high impact and deep tech start-ups and scale ups. The EIC Fund provides patient capital and invests in companies from any sector, across all EU countries and countries associated to Horizon 2020.<\/p>

The Fund pays particular attention to empower and support female founders as well as contributing to reduce the innovation divide among EU countries.<\/p>

The EIC Fund aims to fill a critical financing gap and its main purpose is not to maximize financial investment returns, but to have a high impact by accompanying companies with and disruptive technologies in their growth. Its objective is to crowd in market players, further sharing risks by building a large network of capital providers and strategic partners suitable for co-investments and follow on funding.<\/p>

About EIT Digital Accelerator<\/span><\/strong><\/p>

EIT Digital Accelerator supports international growth of European digital tech scaleups by helping them raise venture capital and access new markets. Since 2012, EIT Digital Accelerator\u2019s team of venture financing and business experts has been working with 300+ companies across Europe who collectively raised over \u20ac1 billion in investment.<\/p>

www.eitdigital.eu\/accelerator\/<\/a><\/p>

About ADVITOS<\/strong><\/p>

ADVITOS developed the CE-marked and globally patented ADVOS technology (ADVanced Organ Support) \u2013 the only therapy worldwide offering multi-organ support integrated in one single device. The ADVOS therapy improves survival of ICU patients by simultaneously supporting all three main detoxification organs: the liver, the lung, and the kidney. The solution allows fluid-based elimination of: water-soluble toxins (kidney), protein-bound toxins (liver and kidney), and CO2 (lungs). In addition, the ADVOS therapy enables treatment of acid-base disbalances through patient-individual correction of the blood pH value. The ADVOS therapy is used in intensive care units at 20 leading hospitals throughout Germany and is on its way to entering the international market. ADVITOS receives funding from the European Union\u2019s Horizon 2020 research and innovation programme.
www.advitos.com<\/a><\/p>

Participants in the transaction<\/strong><\/p>

Finance & Tax-Advisory: Eight Advisory (Marc Niclas, Jan-Ole Burchert, Manuel Wahl)<\/p>

EIT Digital Accelerator (Daniel Michel)<\/p>

Legal: Goodwin Procter LLP (Gregor Klenk, Joana Pamukova), Implid Legal (Beno\u00eet Lespinasse)<\/p>

Heussen Rechtsanwaltgesellschaft mnH (Cornelia Weber; Gerhard Pischel), Field Fischer (Andreas Driver),<\/p>

CMS (Henrik Drinkuth; Arian Nazari-Khanachayi, Frederike Volkmann), Oppenhoff (Johannes Janning)<\/p>

IP: <\/a>Franck Tetaz Intellectual Property, Graf von Stosch Patentanwaltsgesellschaft mbH<\/p>

Press Contacts
<\/strong>ADVITOS<\/strong><\/p>

Josephin Letsch<\/p>

Tel. +49 (0) 170 45 83 38 3 \/\/ +49 (0) 89 4111842-27<\/p>

E-Mail: marketing@advitos.com<\/a><\/p>

Credit Mutuel Equity \u2013 Credit Mutuel Innovation
<\/strong>Charles Barker<\/p>

Georg Schattney\/Jan P. Sefrin
Tel. +49 (0)69 79 40 90-44\/26
E-Mail: cmequity@charlesbarker.de<\/a><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

10.06.2021 Munich \/ Paris \/ Frankfurt am Main ADVITOS GmbH (\u201cADVITOS\u201d), a Munich-based medical technology company, today announced the completion of a EUR 20 million financing round. The financing round was led by Cr\u00e9dit Mutuel Equity via its two subsidiaries Cr\u00e9dit Mutuel Equity Germany and Cr\u00e9dit Mutuel Innovation. In addition, ADVITOS received funding from the […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[22],"tags":[],"class_list":{"0":"post-6708","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-pressemitteilungen"},"yoast_head":"\nADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund - ADVITOS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund - ADVITOS\" \/>\n<meta property=\"og:description\" content=\"10.06.2021 Munich \/ Paris \/ Frankfurt am Main ADVITOS GmbH (\u201cADVITOS\u201d), a Munich-based medical technology company, today announced the completion of a EUR 20 million financing round. The financing round was led by Cr\u00e9dit Mutuel Equity via its two subsidiaries Cr\u00e9dit Mutuel Equity Germany and Cr\u00e9dit Mutuel Innovation. In addition, ADVITOS received funding from the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/\" \/>\n<meta property=\"og:site_name\" content=\"ADVITOS\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-10T14:51:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-10T10:08:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/advitos.com\/wp-content\/uploads\/2022\/07\/advitos_presse_europoean-innovation-council-fund-logo.jpg\" \/>\n<meta name=\"author\" content=\"Tina Thanner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tina Thanner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/\"},\"author\":{\"name\":\"Tina Thanner\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/person\\\/927e470338081f0eaffac79d5fd5a41f\"},\"headline\":\"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund\",\"datePublished\":\"2021-06-10T14:51:21+00:00\",\"dateModified\":\"2023-08-10T10:08:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/\"},\"wordCount\":1649,\"publisher\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/advitos_presse_europoean-innovation-council-fund-logo.jpg\",\"articleSection\":[\"Pressemitteilungen\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/\",\"url\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/\",\"name\":\"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund - ADVITOS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/advitos_presse_europoean-innovation-council-fund-logo.jpg\",\"datePublished\":\"2021-06-10T14:51:21+00:00\",\"dateModified\":\"2023-08-10T10:08:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#primaryimage\",\"url\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/advitos_presse_europoean-innovation-council-fund-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/advitos_presse_europoean-innovation-council-fund-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/advitos.com\\\/en\\\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/advitos.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#website\",\"url\":\"https:\\\/\\\/advitos.com\\\/\",\"name\":\"ADVITOS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/advitos.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#organization\",\"name\":\"ADVITOS\",\"url\":\"https:\\\/\\\/advitos.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-ADVITOS_Logo_en.png\",\"contentUrl\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-ADVITOS_Logo_en.png\",\"width\":300,\"height\":79,\"caption\":\"ADVITOS\"},\"image\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/person\\\/927e470338081f0eaffac79d5fd5a41f\",\"name\":\"Tina Thanner\",\"url\":\"https:\\\/\\\/advitos.com\\\/en\\\/author\\\/tinathanner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund - ADVITOS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/","og_locale":"en_US","og_type":"article","og_title":"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund - ADVITOS","og_description":"10.06.2021 Munich \/ Paris \/ Frankfurt am Main ADVITOS GmbH (\u201cADVITOS\u201d), a Munich-based medical technology company, today announced the completion of a EUR 20 million financing round. The financing round was led by Cr\u00e9dit Mutuel Equity via its two subsidiaries Cr\u00e9dit Mutuel Equity Germany and Cr\u00e9dit Mutuel Innovation. In addition, ADVITOS received funding from the […]","og_url":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/","og_site_name":"ADVITOS","article_published_time":"2021-06-10T14:51:21+00:00","article_modified_time":"2023-08-10T10:08:05+00:00","og_image":[{"url":"https:\/\/advitos.com\/wp-content\/uploads\/2022\/07\/advitos_presse_europoean-innovation-council-fund-logo.jpg","type":"","width":"","height":""}],"author":"Tina Thanner","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tina Thanner","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#article","isPartOf":{"@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/"},"author":{"name":"Tina Thanner","@id":"https:\/\/advitos.com\/#\/schema\/person\/927e470338081f0eaffac79d5fd5a41f"},"headline":"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund","datePublished":"2021-06-10T14:51:21+00:00","dateModified":"2023-08-10T10:08:05+00:00","mainEntityOfPage":{"@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/"},"wordCount":1649,"publisher":{"@id":"https:\/\/advitos.com\/#organization"},"image":{"@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#primaryimage"},"thumbnailUrl":"https:\/\/advitos.com\/wp-content\/uploads\/2022\/07\/advitos_presse_europoean-innovation-council-fund-logo.jpg","articleSection":["Pressemitteilungen"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/","url":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/","name":"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund - ADVITOS","isPartOf":{"@id":"https:\/\/advitos.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#primaryimage"},"image":{"@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#primaryimage"},"thumbnailUrl":"https:\/\/advitos.com\/wp-content\/uploads\/2022\/07\/advitos_presse_europoean-innovation-council-fund-logo.jpg","datePublished":"2021-06-10T14:51:21+00:00","dateModified":"2023-08-10T10:08:05+00:00","breadcrumb":{"@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#primaryimage","url":"https:\/\/advitos.com\/wp-content\/uploads\/2022\/07\/advitos_presse_europoean-innovation-council-fund-logo.jpg","contentUrl":"https:\/\/advitos.com\/wp-content\/uploads\/2022\/07\/advitos_presse_europoean-innovation-council-fund-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/advitos.com\/en\/advitos-a-medical-device-manufacturer-with-a-unique-therapy-for-patients-with-multi-organ-failure-completes-a-20me-financing-round-led-by-credit-mutuel-equity-with-a-co-investment-from-the-eu-eic-f\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/advitos.com\/en\/"},{"@type":"ListItem","position":2,"name":"ADVITOS, a medical device manufacturer with a unique therapy for patients with multi organ failure, completes a 20m\u20ac financing round led by Cr\u00e9dit Mutuel Equity, with a co-investment from the EU EIC Fund"}]},{"@type":"WebSite","@id":"https:\/\/advitos.com\/#website","url":"https:\/\/advitos.com\/","name":"ADVITOS","description":"","publisher":{"@id":"https:\/\/advitos.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/advitos.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/advitos.com\/#organization","name":"ADVITOS","url":"https:\/\/advitos.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advitos.com\/#\/schema\/logo\/image\/","url":"https:\/\/advitos.com\/wp-content\/uploads\/2025\/03\/cropped-ADVITOS_Logo_en.png","contentUrl":"https:\/\/advitos.com\/wp-content\/uploads\/2025\/03\/cropped-ADVITOS_Logo_en.png","width":300,"height":79,"caption":"ADVITOS"},"image":{"@id":"https:\/\/advitos.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/advitos.com\/#\/schema\/person\/927e470338081f0eaffac79d5fd5a41f","name":"Tina Thanner","url":"https:\/\/advitos.com\/en\/author\/tinathanner\/"}]}},"_links":{"self":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/posts\/6708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/comments?post=6708"}],"version-history":[{"count":0,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/posts\/6708\/revisions"}],"wp:attachment":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/media?parent=6708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/categories?post=6708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/tags?post=6708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}